News Digest / Ticker: XFOR

Ticker: XFOR

10:02am, Thursday, May 01, 2025

X4 Pharmaceuticals Reports Q1 2025 Gains Despite Ongoing Financial Challenges and High Expenses

X4 Pharmaceuticals, Inc. (NASDAQ: XFOR) has recently reported its financial results for the quarter ending March 31, 2025. The company is primarily focused on the development and commercialization of novel therapeutics for rare diseases, with its lead product, XOLREMDI, recently approved for the ...